西拉多巴

化合物

西拉多巴(英語:Ciladopa,研發代號:AY-27,110)是一種含氮有機化合物,化學式C21H26N2O4化學結構多巴胺相似,能作為多巴胺激動劑[1]。曾被研究作為抗帕金森病的藥物,但由於動物實驗中存在癌變風險而停用[2][3][4][5]

西拉多巴
臨床資料
給藥途徑Oral
ATC碼
  • 未分配
法律規範狀態
法律規範
  • Uncontrolled
識別資訊
  • 2-{4-[(2S)-2-(3,4-dimethoxyphenyl)-2-hydroxyethyl]piperazin-1-yl}cyclohepta-2,4,6-trien-1-one
CAS號80109-27-9
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard英語CompTox Chemicals Dashboard (EPA)
化學資訊
化學式C21H26N2O4
摩爾質量370.45 g·mol−1
3D模型(JSmol英語JSmol
  • O=C3/C=C\C=C/C=C3/N2CCN(C[C@@H](O)c1ccc(OC)c(OC)c1)CC2

參考文獻

編輯
  1. ^ Voith K. The comparative long-term effects of ciladopa (AY-27,110), a chemically novel dopaminergic agonist, in 6-OHDA-lesioned and intact rats. Psychopharmacology. 1985, 85 (4): 405–9. PMID 3927334. S2CID 1573473. doi:10.1007/BF00429654. 
  2. ^ Koller WC, Fields JZ, Gordon JH, Perlow MJ. Evaluation of ciladopa hydrochloride as a potential anti-Parkinson drug. Neuropharmacology. September 1986, 25 (9): 973–9. PMID 3774130. S2CID 19175441. doi:10.1016/0028-3908(86)90190-5. 
  3. ^ Weiner WJ, Factor SA, Sanchez-Ramos J, Berger J. A double-blind evaluation of ciladopa in Parkinson's disease. Movement Disorders. 1987, 2 (3): 211–7. PMID 3332914. S2CID 31784301. doi:10.1002/mds.870020308. 
  4. ^ Lieberman A, Gopinathan G, Neophytides A, Pasternack P, Goldstein M. Advanced Parkinson's disease: use of partial dopamine agonist, ciladopa. Neurology. May 1987, 37 (5): 863–5. PMID 3574692. S2CID 25273606. doi:10.1212/wnl.37.5.863. 
  5. ^ Lang AE. Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine". The Canadian Journal of Neurological Sciences. August 1987, 14 (3 Suppl): 474–82. PMID 3315148. doi:10.1017/s031716710003794x . 

外部連結

編輯